Literature DB >> 24990666

Tocolysis for acute preterm labor: does anything work.

Kjell Haram1, Jan Helge Seglem Mortensen, John C Morrison.   

Abstract

The central rationale of tocolysis for preterm labor (PTL) is to delay delivery for at least 48 h to allow for transfer of the mother to a tertiary facility and for corticosteroids to induce surfactant production in fetal lungs. Beta-mimetics decrease the number of women in preterm labor giving birth within 48 h without reducing adverse neonatal outcomes. Calcium channel blockers inclusive of nifedipine decrease the adverse neonatal outcomes by significantly delaying delivery. Atosiban has the best maternal and fetal safety profile but does not seem to reduce neonatal complications. Magnesium sulfate is controversial as a tocolytic, but is valuable as a neuroprotective agent and for treatment of eclamptic seizures. Indomethacin may be a reasonable first choice for acute tocolytsis in gestational ages less than 32 weeks' gestation. Prolonged use (>48 h) should be avoided. Transdermal nitroglycerin can reduce neonatal morbidity and mortality as a result of decreased risk of birth before 28 weeks' gestation. Nifedipine may be a reasonable first choice because it is easy to administer and also of limited side effects relative to β2-mimetics. Tocolysis does not appear to significantly lengthen the gestational age beyond seven days.

Entities:  

Keywords:  Atosiban; beta-mimetic; calcium channel blockers; indomethacin; magnesium sulfate; nitroglycerine; preterm delivery; tocolytics

Mesh:

Substances:

Year:  2014        PMID: 24990666     DOI: 10.3109/14767058.2014.918095

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  7 in total

1.  Factors associated with higher oxytocin requirements in labor.

Authors:  Heather A Frey; Methodius G Tuuli; Sarah K England; Kimberly A Roehl; Anthony O Odibo; George A Macones; Alison G Cahill
Journal:  J Matern Fetal Neonatal Med       Date:  2014-09-29

2.  Success rate in preterm uterine contraction inhibition with tocolytic agents in a tertiary care center.

Authors:  Duangsamorn Kiatsuda; Jadsada Thinkhamrop; Witoon Prasertcharoensuk
Journal:  Int J Womens Health       Date:  2016-11-15

Review 3.  Obesity in pregnancy: a novel concept on the roles of adipokines in uterine contractility.

Authors:  Judit Hajagos-Tóth; Eszter Ducza; Reza Samavati; Sandor G Vari; Robert Gaspar
Journal:  Croat Med J       Date:  2017-04-14       Impact factor: 1.351

4.  Bryophyllum pinnatum enhances the inhibitory effect of atosiban and nifedipine on human myometrial contractility: an in vitro study.

Authors:  S Santos; C Haslinger; M Mennet; U von Mandach; M Hamburger; A P Simões-Wüst
Journal:  BMC Complement Altern Med       Date:  2019-11-04       Impact factor: 3.659

5.  Hexoprenaline Compared with Atosiban as Tocolytic Treatment for Preterm Labor.

Authors:  Ebba Kirchhoff; Verena Schneider; Gerhard Pichler; Philipp Reif; Josef Haas; Maike Joksch; Corinna Mager; Christian Schmied; Wolfgang Schöll; Elisabeth Pichler-Stachl; Daniela Gold
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-08-10       Impact factor: 2.754

6.  Ritodrine in external cephalic version: is it effective and safe?

Authors:  Sin Ae Kim; Eun-Hwan Cha; Kyoung-Chul Chun; Young Ah Kim; Jae-Whoan Koh; Jung Yeol Han; Jong Hee Hwang
Journal:  Obstet Gynecol Sci       Date:  2022-07-29

7.  Efficacy and side effect of ritodrine and magnesium sulfate in threatened preterm labor.

Authors:  Min Kyoung Kim; Seung Mi Lee; Jung Won Oh; So Yeon Kim; Hye Gyeong Jeong; Sun Min Kim; Chan Wook Park; Jong Kwan Jun; Seo-Kyung Hahn; Joong Shin Park
Journal:  Obstet Gynecol Sci       Date:  2017-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.